Published in Biochem Biophys Res Commun on December 16, 1991
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A (1993) 2.64
Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax (2005) 2.39
Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J (2012) 1.96
Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax (2001) 1.95
Nitric oxide and lung disease. Thorax (1993) 1.77
Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child (1998) 1.76
Multiple roles of nitric oxide in the airways. Thorax (2003) 1.69
Exhaled nitric oxide: a new lung function test. Thorax (1996) 1.64
Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation. Thorax (2005) 1.62
Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest (1998) 1.60
Reduced upper airway nitric oxide in cystic fibrosis. Arch Dis Child (1996) 1.50
Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child (1996) 1.42
Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax (1999) 1.40
Measurement of exhaled nitric oxide in man. Thorax (1993) 1.35
Reference values for exhaled nitric oxide (reveno) study. Respir Res (2006) 1.21
Biomonitoring and biomarkers: exposure assessment will never be the same. Environ Health Perspect (2006) 1.15
Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations. Thorax (1998) 1.15
Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children. Respir Res (2006) 1.13
Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J (1994) 1.11
Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. J Clin Invest (1994) 1.11
Technologies for Clinical Diagnosis Using Expired Human Breath Analysis. Diagnostics (Basel) (2015) 1.09
Cardiovascular biomarkers in exhaled breath. Prog Cardiovasc Dis (2012) 1.09
Exhaled breath analysis: the new frontier in medical testing. J Breath Res (2008) 1.03
Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J Clin Invest (1995) 1.01
Effect of inhaled L-arginine on exhaled nitric oxide in normal and asthmatic subjects. Thorax (1998) 1.00
Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests. Thorax (2005) 0.99
Controlled low flow off line sampling of exhaled nitric oxide in children. Thorax (2001) 0.96
Nitric oxide in adaptation to altitude. Free Radic Biol Med (2012) 0.96
Nasal nitric oxide in man. Thorax (1999) 0.94
Partitioned exhaled nitric oxide to non-invasively assess asthma. Respir Physiol Neurobiol (2008) 0.93
Novel hand-held device for exhaled nitric oxide-analysis in research and clinical applications. J Clin Monit Comput (2004) 0.93
Examination of the Staphylococcus aureus nitric oxide reductase (saNOR) reveals its contribution to modulating intracellular NO levels and cellular respiration. Mol Microbiol (2015) 0.92
Exhaled breath analysis: The new interface between medicine and engineering. Adv Powder Technol (2009) 0.90
Detection of nitric oxide in exhaled air during administration of nitroglycerin in vivo. Br J Pharmacol (1994) 0.89
Mouse nasal epithelial innate immune responses to Pseudomonas aeruginosa quorum-sensing molecules require taste signaling components. Innate Immun (2013) 0.88
Elevation in exhaled nitric oxide predicts for radiation pneumonitis. Int J Radiat Oncol Biol Phys (2011) 0.86
Lung oxidative damage by hypoxia. Oxid Med Cell Longev (2012) 0.86
Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis. Allergy Asthma Proc (2013) 0.86
Taste receptors in innate immunity. Cell Mol Life Sci (2014) 0.86
Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology. J Breath Res (2008) 0.85
The promotion of patent airways and inhibition of antigen-induced bronchial obstruction by endogenous nitric oxide. Br J Pharmacol (1995) 0.84
Exhaled NO during graded changes in inhaled oxygen in man. Thorax (1997) 0.84
Mechanisms of nitric oxide generation from nitroglycerin and endogenous sources during hypoxia in vivo. Br J Pharmacol (2002) 0.83
Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma. Thorax (2003) 0.82
Exhaled nitric oxide in diagnosis and management of respiratory diseases. Ann Thorac Med (2009) 0.81
Nitric oxide in asthma physiopathology. ISRN Allergy (2011) 0.80
Exhaled nitric oxide measurements in the first 2 years of life: methodological issues, clinical and epidemiological applications. Ital J Pediatr (2009) 0.80
Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease. Br Heart J (1994) 0.79
Multiple flow rates measurement of exhaled nitric oxide in patients with sarcoidosis: a pilot feasibility study. Sarcoidosis Vasc Diffuse Lung Dis (2009) 0.79
Exhaled nitric oxide - circadian variations in healthy subjects. Eur J Med Res (2009) 0.79
Decreased exhaled nitric oxide in subjects with HIV infection. Thorax (1997) 0.79
Noninvasive effects measurements for air pollution human studies: methods, analysis, and implications. J Expo Sci Environ Epidemiol (2015) 0.79
Exhaled nitric oxide in stable chronic obstructive pulmonary disease. Ann Thorac Med (2009) 0.78
Increased expired NO and roles of CO2 and endogenous NO after venous gas embolism in rabbits. Eur J Appl Physiol (2006) 0.77
Fractional exhaled nitric oxide-measuring devices: technology update. Med Devices (Auckl) (2016) 0.77
Treatment of newborn infants with inhaled nitric oxide. Arch Dis Child Fetal Neonatal Ed (1995) 0.77
Evaluation of functional, autonomic and inflammatory outcomes in children with asthma. World J Clin Cases (2015) 0.77
Greater nasal nitric oxide output during inhalation: effects on air temperature and water content. Respir Physiol Neurobiol (2008) 0.77
Beta-adrenoceptor agonist stimulation of pulmonary nitric oxide production in the rabbit. Br J Pharmacol (1999) 0.76
Fractional exhaled nitric oxide in healthy Tibetans at high altitude. Med Sci Monit (2014) 0.76
Nitric oxide and exercise in the horse. J Physiol (1996) 0.75
Use of exhaled nitric oxide in children with bronchial asthma. Med J Armed Forces India (2015) 0.75
Influence of atmospheric nitric oxide concentration on the measurement of nitric oxide in exhaled air. Thorax (1998) 0.75
An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma. Expert Rev Clin Immunol (2016) 0.75
The Influence of 17 Hours of Normobaric Hypoxia on Parallel Adjustments in Exhaled Nitric Oxide and Airway Function in Lowland Healthy Adults. High Alt Med Biol (2017) 0.75
Real-Time Analysis of Isoprene in Breath by Using Ultraviolet-Absorption Spectroscopy with a Hollow Optical Fiber Gas Cell. Sensors (Basel) (2016) 0.75
Exhaled and nasal nitric oxide in laryngectomized patients. BMC Pulm Med (2010) 0.75
The bovine paranasal sinuses: Bacterial flora, epithelial expression of nitric oxide and potential role in the in-herd persistence of respiratory disease pathogens. PLoS One (2017) 0.75
Fractional exhaled nitric oxide: comparison between portable devices and correlation with sputum eosinophils. Allergy Asthma Immunol Res (2015) 0.75
Increase in exhaled nitric oxide and protective role of the nitric oxide system in experimental pulmonary embolism. Br J Pharmacol (2007) 0.75
Bayesian estimation of physiological parameters governing a dynamic two-compartment model of exhaled nitric oxide. Physiol Rep (2017) 0.75
Pulmonary 15NO uptake in man. Pflugers Arch (2003) 0.75
L-arginine reverses cigarette-induced reduction of fractional exhaled nitric oxide in asthmatic smokers. Inflammopharmacology (2009) 0.75
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (1988) 18.41
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (1976) 13.19
Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (1986) 9.93
Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol (1990) 8.85
Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A (1989) 8.34
Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci U S A (1989) 7.79
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun (1988) 7.77
Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet (1989) 7.69
Nitric oxide synthases in mammals. Biochem J (1994) 6.50
A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol (1989) 6.30
Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20
Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol (1990) 5.87
Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol (1971) 5.62
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet (1992) 5.36
Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol (1987) 5.23
A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun (1989) 5.14
The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol (1987) 4.88
Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev (1978) 4.66
Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet (1987) 4.55
Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins (1976) 4.54
Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A (1990) 4.49
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins (1976) 4.44
Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br J Pharmacol (1986) 4.23
Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett (1994) 4.19
Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation. Lancet (1977) 4.11
An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci U S A (1990) 3.98
Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins (1977) 3.74
Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet (1978) 3.74
Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J (1989) 3.70
The chemical structure of prostaglandin X (prostacyclin). Prostaglandins (1976) 3.63
Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases. FEBS Lett (1991) 3.43
Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med (1979) 3.29
Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A (1995) 3.28
Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res (1977) 3.28
The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun (1987) 3.25
Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature (1973) 3.20
Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res (1992) 3.15
Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun (1990) 3.14
Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A (1998) 3.10
An improved method for washing of human platelets with prostacyclin. Thromb Res (1983) 3.07
Control of regional blood flow by endothelium-derived nitric oxide. Hypertension (1990) 2.93
Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature (1976) 2.83
Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem Biophys Res Commun (1989) 2.73
Nitric oxide synthase activities in human myocardium. Lancet (1993) 2.72
Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A (1994) 2.70
Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol (1989) 2.68
Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid. Prostaglandins (1977) 2.67
Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis (1992) 2.63
Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis (1989) 2.58
NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol (1989) 2.53
Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet (1994) 2.53
Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull (1978) 2.51
Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J (1992) 2.51
Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins (1977) 2.48
Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet (1992) 2.44
S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br J Pharmacol (1992) 2.39
The role of TH1 and TH2 cells in a rodent malaria infection. Science (1993) 2.38
Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol (1992) 2.32
Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator. Br J Pharmacol (1988) 2.32
Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun (1990) 2.31
Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun (1990) 2.31
A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation. Prostaglandins (1976) 2.28
Nitric oxide synthase activity in human gynecological cancer. Cancer Res (1994) 2.27
Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol (1999) 2.26
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature (1980) 2.24
Nitric oxide synthase activity in human breast cancer. Br J Cancer (1995) 2.22
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet (1993) 2.20
cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A (1996) 2.17
A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol (1991) 2.15
Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther (1984) 2.12
Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci U S A (1993) 2.10
Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium. Br J Pharmacol (1992) 2.09
Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun (1992) 2.08
Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharmacol (1973) 2.07
The effects of prostagladin endoperoxides and thromboxane A2 on strips of rabbit coeliac artery and certain other smooth muscle preparations [proceedings]. Br J Pharmacol (1976) 2.06
Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet (1990) 2.04
N(G)-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis. Crit Care Med (1998) 2.04
Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection. Proc Natl Acad Sci U S A (2001) 2.03
Mechanism of action of some inhibitors of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A (1986) 2.03
Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin. Br J Pharmacol (1982) 2.01
The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation. J Pharm Pharmacol (1983) 2.00
Kinetic characteristics of nitric oxide synthase from rat brain. Biochem J (1990) 2.00
Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovasc Res (1989) 1.98
Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells. Br J Pharmacol (1991) 1.96
The effect of nitric oxide on cell respiration: A key to understanding its role in cell survival or death. Proc Natl Acad Sci U S A (2000) 1.96
Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol (1990) 1.93
The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. Proc Natl Acad Sci U S A (1995) 1.88
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. Prostaglandins (1978) 1.85
Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem J (1990) 1.85
Comparison of the vasodepressor effects of prostacyclin and 6-oxo-prostaglandin F1alpha with those of prostaglandin E2 in rats and rabbits. Br J Pharmacol (1978) 1.85
Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur J Immunol (1991) 1.84
Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol (1994) 1.82
Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol (1993) 1.79
Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet (1991) 1.78
Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens (1992) 1.77
On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci U S A (1999) 1.76
Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res (1994) 1.74
Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun (1993) 1.73
Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol (1990) 1.72